Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTSI
3601
DELISTED
FTS International, Inc. Common Stock
FTSI
| $406K | ﹤0.01% |
19,563
-1,700
| -8% | -$45.8K |
|
3602
Coda Octopus Group
CODA
$115M
| $404K | ﹤0.01% |
48,223
-3,414
| -7% | -$26.1K |
|
|
BKSC
3603
DELISTED
Bank of South Carolina
BKSC
| $403K | ﹤0.01% |
21,458
-239
| -1% | -$4.48K |
|
|
AXIA
3604
DELISTED
AXIA Energia
AXIA
| $402K | ﹤0.01% |
54,406
-6,685
| -11% | -$47.2K |
|
3605
Serina Therapeutics
SER
$41.7M
| $402K | ﹤0.01% |
6,281
-333
| -5% | -$18K |
|
3606
Orion Group Holdings
ORN
$396M
| $399K | ﹤0.01% |
76,736
-165
| -0.2% | -$819 |
|
3607
Arcturus Therapeutics
ARCT
$214M
| $398K | ﹤0.01% |
36,630
+13,899
| +61% | +$145K |
|
3608
Comp X International
CIX
$388M
| $397K | ﹤0.01% |
27,227
-684
| -2% | -$9.99K |
|
3609
Harrow
HROW
$1.47B
| $397K | ﹤0.01% |
51,063
+1,563
| +3% | +$9.05K |
|
3610
Climb Global Solutions
CLMB
$518M
| $395K | ﹤0.01% |
97,572
+424
| +0.4% | +$1.55K |
|
3611
iShares MSCI Mexico ETF
EWW
$1.89B
| $394K | ﹤0.01% |
8,754
+2,424
| +38% | +$108K |
|
|
IDEX
3612
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $392K | ﹤0.01% |
3,662
-81
| -2% | -$10.8K |
|
3613
Aspen Aerogels
ASPN
$510M
| $390K | ﹤0.01% |
50,345
+57
| +0.1% | +$394 |
|
|
HPF
3614
John Hancock Preferred Income Fund II
HPF
$345M
| $390K | ﹤0.01% |
17,500
| – | – |
|
3615
Espey Mfg & Electronics Corp
ESP
$191M
| $389K | ﹤0.01% |
17,969
-170
| -0.9% | -$3.75K |
|
3616
Bilibili
BILI
$7.53B
| $388K | ﹤0.01% |
20,840
+3,289
| +19% | +$53.4K |
|
3617
Babcock & Wilcox
BW
$1.37B
| $387K | ﹤0.01% |
106,177
-720
| -0.7% | -$2.81K |
|
|
HDV
3618
iShares Core High Dividend ETF
HDV
$15B
| $387K | ﹤0.01% |
19,725
| – | – |
|
|
SREV
3619
DELISTED
ServiceSource International, Inc.
SREV
| $386K | ﹤0.01% |
231,362
+28,244
| +14% | +$36.8K |
|
|
CTRC
3620
DELISTED
Centric Brands Inc. Common Stock
CTRC
| $384K | ﹤0.01% |
176,995
-8,789
| -5% | -$22K |
|
3621
Schwab US Large-Cap Growth ETF
SCHG
$62.7B
| $381K | ﹤0.01% |
32,848
+8,000
| +32% | +$88.2K |
|
|
AMJ
3622
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $381K | ﹤0.01% |
+17,478
| New | +$376K |
|
3623
Celestica
CLS
$39.1B
| $379K | ﹤0.01% |
45,779
-259
| -0.6% | -$1.93K |
|
3624
DNA X Inc
SONM
$5.36M
| $378K | ﹤0.01% |
58
+29
| +100% | +$143K |
|
3625
Barings BDC
BBDC
$975M
| $377K | ﹤0.01% |
+36,655
| New | +$376K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.